未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer吡替尼治疗HER2-positive肝转移晚期乳腺癌的疗效和安全性
Li, Yongxia; Li, Yong; Li, Taolang; He, Mingyuan; Chang, Jianying; Cao, Hui; Luo, Daiqin; Lv, Junyuan; Zou, Yunbi; Zheng, Yuyan; Ran, Li; Yang, Feiyue; Huang, Li; Cheng, Xiaoming
分享
收藏SLC26A9 promotes the initiation and progression of breast cancer by activating the PI3K/AKT signaling pathwaySLC26A9通过激活PI3K/AKT信号通路促进乳腺癌的起始和发展。
Ma, Zhiyuan; Wang, Hu; Zhou, Zhengxing; Lu, Chengli; Zhang, Minglin; Mu, Renmin; Zhang, Chengmin; Yi, Zhiqiang; Deng, Zilin; Zhao, Yingying; Zhu, Jiaxing; Wen, Guorong; Jin, Hai; An, Jiaxing; Tuo, Biguang; Yuan, Peng; Liu, Xuemei; Li, Taolang
分享
收藏
分享
收藏
分享
收藏SLC26A9 promotes colorectal tumorigenesis by modulating Wnt/β-catenin signalingSLC26A9通过调节Wnt/β-catenin信号促进结直肠肿瘤发生
Zhang, Minglin; Ma, Zhiyuan; Yi, Zhiqiang; Wang, Hu; Zhu, Jiaxing; Wen, Guorong; Jin, Hai; An, Jiaxing; Deng, Zilin; Tuo, Biguang; Li, Taolang; Liu, Xuemei
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏The efficacy and safety of trastuzumab and pertuzumab in combination with different chemotherapy regimens for neoadjuvant treatment of HER2-posotive breast cancer: a multicenter real-world study in China
Qi, Xiaowei; Hu, Hong; Chen, Wenlin; Yan, Xu; Shu, Liu; Fang, Yanman; Li, Taolang; Jia, Ming; Zhou, Sihai; Fan, Chai; Liang, Yueyang; Fan, Yuanming; Zhang, Yi; Tang, Peng; Jun, Jiang; Nie, Jianyun; Chen, Li; Wang, Shushu
分享
收藏